“I have always been interested in answering the fundamental questions of what events initiate cancer, and I believe that leukemia can be used as a model to answer these questions.”
Guido Marcucci, M.D., thinks of acute myeloid leukemia (AML) as the “prototype of cancer and how cancer develops,” which makes it a prime target for intensive research, and the focus of much of Dr. Marcucci's distinguished career.
Dr. Marcucci joined City of Hope in 2014 from Ohio State University, where he was a professor of internal medicine, molecular virology, immunology, medical genetics and pharmaceutics in the division of hematology at the university’s comprehensive cancer center.
A nationally-recognized authority on leukemia, Dr. Marcucci has lectured around the world and authored more than 270 scholarly papers on the subject. His ultimate goal is to make leukemia a thing of the past. He has received numerous competitive NCI grants for his clinical and research work focused on the pathogenesis, treatment and prognostic assessment of patients with acute myeloid leukemia. Dr. Marcucci currently serves on the editorial board of three journals, including Blood and the Journal of Clinical Oncology.
“I know what a devastating disease leukemia can be for patients and their families,” he says. “I would love one day to be able to say that I helped to alleviate their suffering.”